NCT05676749 2026-01-05C-TIL051 in Non-Small Cell Lung CancerAbelZeta Inc.Phase 1 Terminated1 enrolled
NCT04136756 2023-06-15NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin LymphomaNektar TherapeuticsPhase 1 Completed30 enrolled